Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2021

Feb 03, 2022

SELL
$198.88 - $227.6 $4,375 - $5,007
-22 Closed
0 $0
Q3 2021

Oct 05, 2021

SELL
$212.27 - $248.7 $10,825 - $12,683
-51 Reduced 69.86%
22 $5,000
Q4 2020

Feb 02, 2021

SELL
$216.38 - $257.67 $4,543 - $5,411
-21 Reduced 22.34%
73 $17,000
Q2 2020

Jul 28, 2020

BUY
$197.81 - $242.74 $4,351 - $5,340
22 Added 30.56%
94 $22,000
Q1 2020

Apr 22, 2020

SELL
$182.24 - $241.7 $12,210 - $16,193
-67 Reduced 48.2%
72 $15,000
Q4 2019

Jan 22, 2020

BUY
$189.21 - $243.2 $26,300 - $33,804
139 New
139 $34,000

Others Institutions Holding AMGN

About AMGEN INC


  • Ticker AMGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 534,931,008
  • Market Cap $169B
  • Description
  • Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...
More about AMGN
Track This Portfolio

Track Savior LLC Portfolio

Follow Savior LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Savior LLC, based on Form 13F filings with the SEC.

News

Stay updated on Savior LLC with notifications on news.